AAAAAA

   
Results: 1-15 |
Results: 15
Protein and energy metabolism in chronic bacterial infection: studies in melioidosis
Authors: Paton, NI Angus, B Chaowagul, W Simpson, AJ Suputtamongkol, Y Elia, M Calder, G Milne, E White, NJ Griffen, GE
Citation: Ni. Paton et al., Protein and energy metabolism in chronic bacterial infection: studies in melioidosis, CLIN SCI, 100(1), 2001, pp. 101-110
Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis (vol 49, pg 445, 2000)
Authors: Angus, BJ Smith, MD Suputtamongkol, Y Mattic, H Walsh, AL Wuthiekanun, V Chaowagul, W White, NJ
Citation: Bj. Angus et al., Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis (vol 49, pg 445, 2000), BR J CL PH, 50(2), 2000, pp. 183-191
Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis
Authors: Angus, BJ Smith, MD Suputtamongkol, Y Mattie, H Walsh, AL Wuthiekanun, V Chaowagul, W White, NJ
Citation: Bj. Angus et al., Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis, BR J CL PH, 49(5), 2000, pp. 445-452
A double-blind placebo-controlled study of an infusion of lexipafant (platelet-activating factor receptor antagonist) in patients with severe sepsis
Authors: Suputtamongkol, Y Intaranongpai, S Smith, MD Angus, B Chaowagul, W Permpikul, C Simpson, JA Leelarasamee, A Curtis, L White, NJ
Citation: Y. Suputtamongkol et al., A double-blind placebo-controlled study of an infusion of lexipafant (platelet-activating factor receptor antagonist) in patients with severe sepsis, ANTIM AG CH, 44(3), 2000, pp. 693-696
Soluble granzymes are released during human endotoxemia and in patients with severe infection due to gram-negative bacteria
Authors: Lauw, FN Simpson, AJH Hack, CE Prins, JM Wolbink, AM van Deventer, SJH Chaowagul, W White, NJ van der Poll, T
Citation: Fn. Lauw et al., Soluble granzymes are released during human endotoxemia and in patients with severe infection due to gram-negative bacteria, J INFEC DIS, 182(1), 2000, pp. 206-213
Differential antibiotic-induced endotoxin release in severe melioidosis
Authors: Simpson, AJH Opal, SM Angus, BJ Prins, JM Palardy, JE Parejo, NA Chaowagul, W White, NJ
Citation: Ajh. Simpson et al., Differential antibiotic-induced endotoxin release in severe melioidosis, J INFEC DIS, 181(3), 2000, pp. 1014-1019
Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis
Authors: Simpson, AJH Smith, MD Weverling, GJ Suputtamongkol, Y Angus, BJ Chaowagul, W White, NJ van Deventer, SJH Prins, JM
Citation: Ajh. Simpson et al., Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis, J INFEC DIS, 181(2), 2000, pp. 621-625
The CXC chemokines gamma interferon (IFN-gamma)-inducible protein 10 and monokine induced by IFN-gamma are released during severe melioidosis
Authors: Lauw, FN Simpson, AJH Prins, JM van Deventer, SJH Chaowagul, W White, NJ van der Poll, T
Citation: Fn. Lauw et al., The CXC chemokines gamma interferon (IFN-gamma)-inducible protein 10 and monokine induced by IFN-gamma are released during severe melioidosis, INFEC IMMUN, 68(7), 2000, pp. 3888-3893
Recent advances in the treatment of severe melioidosis
Authors: Chaowagul, W
Citation: W. Chaowagul, Recent advances in the treatment of severe melioidosis, ACT TROP, 74(2-3), 2000, pp. 133-137
A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis
Authors: Chaowagul, W Simpson, AJH Suputtamongkol, Y Smith, MD Angus, BJ White, NJ
Citation: W. Chaowagul et al., A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis, CLIN INF D, 29(2), 1999, pp. 375-380
Comparison of imipenem and ceftazidime as therapy for severe melioidosis
Authors: Simpson, AJH Suputtamongkol, Y Smith, MD Angus, BJ Rajanuwong, A Wuthiekanun, V Howe, PA Walsh, AL Chaowagul, W White, NJ
Citation: Ajh. Simpson et al., Comparison of imipenem and ceftazidime as therapy for severe melioidosis, CLIN INF D, 29(2), 1999, pp. 381-387
Risk factors for melioidosis and bacteremic melioidosis
Authors: Suputtamongkol, Y Chaowagul, W Chetchotisakd, P Lertpatanasuwun, N Intaranongpai, S Ruchutrakool, T Budhsarawong, D Mootsikapun, P Wuthiekanun, V Teerawatasook, N Lulitanond, A
Citation: Y. Suputtamongkol et al., Risk factors for melioidosis and bacteremic melioidosis, CLIN INF D, 29(2), 1999, pp. 408-413
Empirical cephalosporin treatment of melioidosis
Authors: Chaowagul, W Simpson, AJH Suputtamongkol, Y White, NJ
Citation: W. Chaowagul et al., Empirical cephalosporin treatment of melioidosis, CLIN INF D, 28(6), 1999, pp. 1328-1328
Polymorphism in the promoter region of tumor necrosis factor-alpha gene isassociated with severe melioidosis
Authors: Nuntayanuwat, S Dharakul, T Chaowagul, W Songsivilai, S
Citation: S. Nuntayanuwat et al., Polymorphism in the promoter region of tumor necrosis factor-alpha gene isassociated with severe melioidosis, HUMAN IMMUN, 60(10), 1999, pp. 979-983
Elevated plasma concentrations of interferon (IFN)-gamma and the IFN-gamma-inducing cytokines interleukin (IL)-18, IL-12, and IL-15 in severe melioidosis
Authors: Lauw, FN Simpson, AJH Prins, JM Smith, MD Kurimoto, M van Deventer, SJH Speelman, P Chaowagul, W White, NJ van der Poll, T
Citation: Fn. Lauw et al., Elevated plasma concentrations of interferon (IFN)-gamma and the IFN-gamma-inducing cytokines interleukin (IL)-18, IL-12, and IL-15 in severe melioidosis, J INFEC DIS, 180(6), 1999, pp. 1878-1885
Risultati: 1-15 |